PACB vs. SPY
Compare and contrast key facts about Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PACB or SPY.
Correlation
The correlation between PACB and SPY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PACB vs. SPY - Performance Comparison
Key characteristics
PACB:
-0.68
SPY:
2.21
PACB:
-0.98
SPY:
2.93
PACB:
0.88
SPY:
1.41
PACB:
-0.82
SPY:
3.26
PACB:
-1.08
SPY:
14.43
PACB:
73.88%
SPY:
1.90%
PACB:
117.89%
SPY:
12.41%
PACB:
-97.65%
SPY:
-55.19%
PACB:
-96.15%
SPY:
-2.74%
Returns By Period
In the year-to-date period, PACB achieves a -79.92% return, which is significantly lower than SPY's 25.54% return. Over the past 10 years, PACB has underperformed SPY with an annualized return of -12.48%, while SPY has yielded a comparatively higher 12.97% annualized return.
PACB
-79.92%
14.53%
34.01%
-80.10%
-17.95%
-12.48%
SPY
25.54%
-0.42%
8.90%
25.98%
14.66%
12.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PACB vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PACB vs. SPY - Dividend Comparison
PACB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.86%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 0.86% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
PACB vs. SPY - Drawdown Comparison
The maximum PACB drawdown since its inception was -97.65%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PACB and SPY. For additional features, visit the drawdowns tool.
Volatility
PACB vs. SPY - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) has a higher volatility of 26.23% compared to SPDR S&P 500 ETF (SPY) at 3.72%. This indicates that PACB's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.